Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/21/2008EP1599206A4 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
05/21/2008EP1569595B1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
05/21/2008EP1562958B1 N-sulfonylaminothiazole
05/21/2008EP1562595B1 Diaryl ethers as opioid receptor antagonists
05/21/2008EP1537195A4 Desinfecting composition
05/21/2008EP1517705B1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
05/21/2008EP1482924B1 Cathepsin cysteine protease inhibitors
05/21/2008EP1456206B1 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/21/2008EP1448591B1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations
05/21/2008EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/21/2008EP1434773B1 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/21/2008EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/21/2008EP1379492B1 Inhibitor of monoamine uptake
05/21/2008EP1372652B1 Combination of docetaxel and flavopiridol
05/21/2008EP1366158B1 Trp8 markers for cancer
05/21/2008EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
05/21/2008EP1326838B1 Novel crystalline forms of a factor xa inhibitor
05/21/2008EP1319069B1 Compositions and methods for the therapy and diagnosis of lung cancer
05/21/2008EP1313453B1 Particulate vectors for improving oral absorption of active principles
05/21/2008EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods
05/21/2008EP1284740B1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds
05/21/2008EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors
05/21/2008EP1272048B1 Method for the fractionation of oil and polar lipid-containing native raw materials
05/21/2008EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
05/21/2008EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
05/21/2008EP1249239B1 Antipruritic agents for external use
05/21/2008EP1227837B1 Method of inducing and/or enhancing an immune response to tumor antigens
05/21/2008EP1183253B1 C7 ester substituted taxanes as antitumor agents
05/21/2008EP1161262B1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
05/21/2008EP1140088B1 Controlled/modified release oral methylphenidate formulations
05/21/2008EP1096952B1 Polysaccharide vaccine for staphylococcal infections
05/21/2008EP0924986B1 Antioxidant derived from lentil and its preparation and uses
05/21/2008EP0911334B1 Quinolinomorphinane derivatives and medicinal use thereof
05/21/2008EP0781138B1 Lipid analogs for treating viral infections
05/21/2008DE20221841U1 Transdermal-Pflaster zum Verabreichen von Fentanyl Transdermal patch for administering fentanyl
05/21/2008DE102006055016A1 Kosmetische Zubereitungen mit Guerbetalkoholen Cosmetic preparations with Guerbet
05/21/2008DE102006054690A1 Carbonyl-substituierte Titanocene Carbonyl-substituted titanocene
05/21/2008DE102006054535A1 Progesteronrezeptorantagonisten Progesterone receptor antagonists
05/21/2008DE102006054005A1 Neue Polymorphe von New polymorphs of 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
05/21/2008CN101184850A Branched starch, process for production thereof, and use thereof
05/21/2008CN101184841A Modulation of exon recognition in pre-mRNA by interfering with the binding of SR proteins and by interfering with secondary RNA structure.
05/21/2008CN101184761A Spiro-oxindole compounds and their uses as therapeutic agents
05/21/2008CN101184759A Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
05/21/2008CN101184758A Novel compounds
05/21/2008CN101184757A Heterocyclic spiro-compounds as aldosterone synthase inhibitors
05/21/2008CN101184756A Isoflavonoid dimers
05/21/2008CN101184754A Ergoline derivatives and their use as chemokine receptor ligands
05/21/2008CN101184753A Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
05/21/2008CN101184752A Pyrimidine derivatives for use as anticancer agents
05/21/2008CN101184751A Quinazolines and their use as AURORA kinase inhibitors
05/21/2008CN101184750A Pyrimidines as IGF-inhibitors
05/21/2008CN101184749A Spirocyclic heterocyclic derivatives and methods of their use
05/21/2008CN101184739A Polycyclic oxadiazoles or isoxazoles and their use as S1P receptor ligands
05/21/2008CN101184738A Purified form of tanaproget
05/21/2008CN101184735A Crystalline form of benzazepinium maleate derivative
05/21/2008CN101184734A Compositions and methods of treating cell proliferation disorders
05/21/2008CN101184733A Novel piperidine carboxylic acid amide derivatives
05/21/2008CN101184731A New sulfonylindoline compounds
05/21/2008CN101184730A New hybrid oligomers. their preparation process and pharmaceutical compositions containing them
05/21/2008CN101184729A Inhibitors of cytosolic phospholipase a2
05/21/2008CN101184728A Peptide deformylase (PDF) inhibitors 4
05/21/2008CN101184725A N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
05/21/2008CN101184543A Method of preparing lycopene-enriched formulations that are free of organic solvents, formulations thus obtained, compositions comprising said formulations and use of same
05/21/2008CN101184511A Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen
05/21/2008CN101184507A Treatment of inflammatory bowel disease (ibd)
05/21/2008CN101184496A Pharmaceutical preparation for recovery from fatigue
05/21/2008CN101184495A Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
05/21/2008CN101184494A Method for preparing and separating phospholipids
05/21/2008CN101184493A Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues
05/21/2008CN101184492A Method for the treatment of noise phobia in companion animals
05/21/2008CN101184491A Selective apoptotic induction in cancer cells including activation of procaspase-3
05/21/2008CN101184490A Piperazinyl substituted cyclohexane-1,4-diamines
05/21/2008CN101184489A Pharmaceutical composition
05/21/2008CN101184488A Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
05/21/2008CN101184487A Bicyclic pyrazole compounds as antibacterial agents
05/21/2008CN101184486A Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
05/21/2008CN101184485A Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
05/21/2008CN101184484A Novel use of organic compounds
05/21/2008CN101184483A An entacapone-containging oral dosage form
05/21/2008CN101184482A Compositions and methods for inhibiting gastric acid secretion
05/21/2008CN101184481A Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
05/21/2008CN101184480A Treatment of intestinal conditions
05/21/2008CN101184475A Transdermal absorption accelerator
05/21/2008CN101184395A Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
05/21/2008CN101182563A Method for preparing lactulose by co-immobilized lactose enzyme and glucose isomerase
05/21/2008CN101182562A Method for producing extracellular polysaccharide through golden fungus liquid fermentation and uses thereof
05/21/2008CN101182345A Ursolic acid oxazoline new drugs having antiphlogistic activity and preparation method thereof
05/21/2008CN101182332A Manganese complexes having antitumor and affecting mitochondria functions
05/21/2008CN101182331A Adefovir dipivoxil ester colalin derivatives as well as preparation method and uses thereof
05/21/2008CN101182325A Intravenous administration bilobalide B and extraction method
05/21/2008CN101182321A Indolizine heterocyclic nitrogen naphthoquinone derivatives as well as preparation method and anticancer use thereof
05/21/2008CN101182320A Compound capable of inhibiting growth of bacillus tubercle and uses thereof
05/21/2008CN101182317A Sulfur-containing proanthocyanidin oligomer composition and production method thereof
05/21/2008CN101182315A Substituted benzamido methyl formate compound as well as preparation method and uses thereof
05/21/2008CN101182309A Targeted leading compounds having latent anticancer actives
05/21/2008CN101182298A Compound 2-hydroxy-5-butyrylamino benzoic acid and uses thereof
05/21/2008CN101182289A 4'-hydroxy-4,6'-dimethoxy dihydrocharcone and method for synthesizing the same
05/21/2008CN101181650A Bracket for controlling releasing and elution of tranilast medicament coating
05/21/2008CN101181639A Medicament for curing ague completely
1 ... 3256 3257 3258 3259 3260 3261 3262 3263 3264 3265 3266 3267 3268 3269 3270 3271 3272 3273 3274 3275 3276 ... 7860